Press Releases

Quintiles Central Laboratory Receives First Industry Accreditation Dedicated to Biorepository Program

Quintiles today announced that its flagship central laboratory in the U.S. received accreditation from the College of American Pathologists (CAP) Biorepository Accreditation Program. The first of its kind, this accreditation was developed to ensure biorepositories are following best...

The launch of the first ever global Medical Science Liaison Society.

According to Dr. Samuel Dyer, Chairman of the Board of the MSL Society, “As the MSL role continues to rapidly grow and play an ever increasingly important role in the success of pharmaceutical and biotech companies, there has...

Nuron Biotech Acquires Commercial, Preventive Vaccine Meningitecâ„¢ from Pfizer

Nuron Biotech Inc., a specialty biologics and vaccines company, today announced it has acquired from Pfizer Inc. Meningitecâ„¢, which is a vaccine for the prevention of invasive disease caused by Neisseria meningitidis serogroup C. Meningitec is a preservative...

Organization seeks help to build clinic to fight HIV and AIDS in DR’s sugarcane plantations rural enclaves

Batey Relief Alliance (BRA) recently launched a fundraising campaign to raise US $100,000 to build a medical clinic in one of Dominican Republic's most impoverished, vulnerable and abandoned rural communities in the province Monte Plata—Batey Cinco Casas to...

Exact Sciences to participate in Canaccord Genuity Medical Technology & Diagnostics Forum

Exact Sciences Corp. today announced that it will present at the Canaccord Genuity Medical Technology & Diagnostics Forum in New York. Kevin T. Conroy, Exact’s president and chief executive, will make the company’s presentation...

Exact Sciences to participate in Canaccord Genuity Medical Technology & Diagnostics Forum

Exact Sciences Corp. today announced that it will present at the Canaccord Genuity Medical Technology & Diagnostics Forum in New York. Kevin T. Conroy, Exact’s president and chief executive, will make the company’s presentation...

ERYTECH Pharma Signs Licensing and Distribution Agreement with Orphan Europe for GRASPA® in Europe

ERYTECH Pharma, a late stage biopharmaceuticals company focused on orphan oncology and rare diseases, announced today that it has entered into a definitive agreement with Orphan Europe, part of the Recordati Group, granting Orphan Europe exclusive rights for...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read